Manual on Entrepreneur-Ready Technologies of CMFRI

CMFRI presented five entrepreneur- ready technologies in the “Innovation 4 Industry Meet” organized by Zonal Technology Management Centre, Business Planning & Development Unit (ZTMCBPDU), South Zone, CIFT and National Fisheries Development Board held at Visakhapatnam on 8th September 2010 and in the ‘Rural Technology Mela’ organized by National Institute of rural Development at Hyderabad during 2nd to 5th February, 2011. A detailed presentation and exposition including prospective business proposals on the five technologies namely‘Green Mussel extract (GMe)’, ‘Varna (the marine ornamental fish feed)’, ‘Broodstock development, captive breeding and larval production of 17 species of marine ornamental fishes’, ‘Larval production of Cobia fish’ and ‘A device for breeding and culturing marine fish in open sea through cage farming’ were made in the meets. ‘Open sea cage farming in HDPE cage’ and ‘Low cost cage farming in GI cage’ were show-cased in the recently held ICAR-CII Industry Meet organized at NAAS Complex, New Delhi on 23rd May, 2011. The presentation and the exhibition in these meets got the attention of many prospective industrialists/ entrepreneurs which resulted in signing up of a few business proposals

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol

Paromomycin (PMM) has recently been introduced for treatment of visceral leishmaniasis in India. Although no clinical resistance has yet been reported, proactive vigilance should be warranted. The present in vitro study compared the outcome and stability of experimental PMM-resistance induction on promastigotes and intracellular amastigotes. Cloned antimony-resistant L. donovani field isolates from India and Nepal were exposed to stepwise increasing concentrations of PMM (up to 500 µM), either as promastigotes or intracellular amastigotes. One resulting resistant strain was cloned and checked for stability of resistance by drug-free in vitro passage as promastigotes for 20 weeks or a single in vivo passage in the golden hamster. Resistance selection in promastigotes took about 25 weeks to reach the maximal 97 µM inclusion level that did not affect normal growth. Comparison of the IC50 values between the parent and the selected strains revealed a 9 to 11-fold resistance for the Indian and 3 to 5-fold for the Nepalese strains whereby the resistant phenotype was also maintained at the level of the amastigote. Applying PMM pressure to intracellular amastigotes produced resistance after just two selection cycles (IC50 = 199 µM) compared to the parent strain (IC50 = 45 µM). In the amastigote-induced strains/clones, lower PMM susceptibilities were seen only in amastigotes and not at all in promastigotes. This resistance phenotype remained stable after serial in vitro passage as promastigote for 20 weeks and after a single in vivo passage in the hamster. This study clearly demonstrates that a different PMM-resistance phenotype is obtained whether drug selection is applied to promastigotes or intracellular amastigotes. These findings may have important relevance to resistance mechanism investigations and the likelihood of resistance development and detection in the field

Genetic variation at twentythree microsatellite loci in sixteen human populations

Artículo científico -- Universidad de Costa Rica, Instituto de Investigaciones en Salud. 1999We have analysed genetic variation at 23 microsatellite loci in a global sample of 16 ethnically and geographically diverse human populations. On the basis of their ancestral heritage and geographic locations, the studied populations can be divided into five major groups, viz. African, Caucasian, Asian Mongoloid, American Indian and Pacific Islander. With respect to the distribution of alleles at the 23 loci, large variability exists among the examined populations. However, with the exception of the American Indians and the Pacific Islanders, populations within a continental group show a greater degree of similarity. Phylogenetic analyses based on allele frequencies at the examined loci show that the first split of the present-day human populations had occurred between the Africans and all of the non-African populations, lending support to an African origin of modern human populations. Gene diversity analyses show that the coefficient of gene diversity estimated from the 23 loci is, in general, larger for populations that have remained isolated and probably of smaller effective sizes, such as the American Indians and the Pacific Islanders. These analyses also demonstrate that the component of total gene diversity, which is attributed to variation between groups of populations, is significantly larger than that among populations within each group. The empirical data presented in this work and their analyses reaffirm that evolutionary histories and the extent of genetic variation among human populations can be studied using microsatellite loci.Universidad de Costa Rica. Instituto de Investigaciones en SaludUCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias de la Salud::Instituto de Investigaciones en Salud (INISA

Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection

Background: In an endeavor to find an orally active and affordable antileishmanial drug, we tested the efficacy of a cationic amphiphilic drug, imipramine, commonly used for the treatment of depression in humans. The only available orally active antileishmanial drug is miltefosine with long half life and teratogenic potential limits patient compliance. Thus there is a genuine need for an orally active antileishmanial drug. Previously it was shown that imipramine, a tricyclic antidepressant alters the protonmotive force in promastigotes, but its in vivo efficacy was not reported. Methodology/Principal Findings: Here we show that the drug is highly active against antimony sensitive and resistant Leishmania donovani in both promastigotes and intracellular amastigotes and in LD infected hamster model. The drug wasfound to decrease the mitochondrial transmembrane potential of Leishmania donovani (LD) promastigotes and purified amastigotes after 8 h of treatment, whereas miltefosine effected only a marginal change even after 24 h. The drug restores defective antigen presenting ability of the parasitized macrophages. The status of the host protective factors TNF a, IFN c and iNOS activity increased with the concomitant decrease in IL 10 and TGF b level in imipramine treated infected hamsters and evolution of matured sterile hepatic granuloma. The 10-day therapeutic window as a monotherapy, showing about 90% clearance of organ parasites in infected hamsters regardless of their SSG sensitivity. Conclusions: This study showed that imipramine possibly qualifies for a new use of an old drug and can be used as an effective orally active drug for the treatment of Kala-azar

On performance of optical buffers with specific number of circulations

Abstract—Deployment of fiber delay lines (FDLs) as a means of contention resolution is analytically studied. We consider a singlewavelength optical link equipped with a single FDL and assume that packets of fixed length arrive to the link asynchronously. The results obtained include accurate equations to calculate the congestion rate for different reservation scenarios including a prereservation scheme as well as a postreservation scheme with a specific number of circulations. Accuracy of the proposed model is validated through simulation. Index Terms—Fiber delay line (FDL), loss rate, optical burst switching (OBS), optical packet switching, queuing system. I

On performance of optical buffers with fixed length packets

Abstract — In this paper, we analytically study the performance of fiber delay line as a means of contention resolution in optical routers. We consider asynchronous arrival of fixed length packets to a single-channel optical link equipped with a single delay line, and investigate the effectiveness of using delay line in improving the loss performance. The results include accurate equations for congestion rate and queuing delay, which are validated through simulation. I